Bank of Montreal’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,304
Closed -$92K 3768
2025
Q2
$92K Buy
11,304
+405
+4% +$3.46K ﹤0.01% 3002
2025
Q1
$85.6K Buy
+10,899
New +$126K ﹤0.01% 2953
2021
Q2
Sell
-1,861
Closed -$57K 4679
2021
Q1
$57K Sell
1,861
-5,092
-73% -$177K ﹤0.01% 3640
2020
Q4
$223K Buy
6,953
+4,568
+192% +$111K ﹤0.01% 3169
2020
Q3
$43K Sell
2,385
-682
-22% -$15.2K ﹤0.01% 3506
2020
Q2
$78K Buy
3,067
+2,638
+615% +$71.2K ﹤0.01% 3208
2020
Q1
$6K Sell
429
-4,005
-90% -$49.8K ﹤0.01% 3640
2019
Q4
$45K Buy
4,434
+1,264
+40% +$10.6K ﹤0.01% 3890
2019
Q3
$29K Buy
3,170
+490
+18% +$3.94K ﹤0.01% 3883
2019
Q2
$21K Sell
2,680
-9,322
-78% -$93.3K ﹤0.01% 4156
2019
Q1
$150K Buy
12,002
+11,556
+2,591% +$125K ﹤0.01% 2871
2018
Q4
$5K Buy
446
+382
+597% +$4.46K ﹤0.01% 4099
2018
Q3
$1K Buy
64
+27
+73% +$344 ﹤0.01% 4586
2018
Q2
$0 Buy
+37
New +$581 ﹤0.01% 4837

Other funds holding RCUS

Bank of Montreal's RCUS Position: Q3 2025 in Review

Bank of Montreal sold out of Arcus Biosciences (RCUS) in Q3 2025, closing a stake of 11,304 shares — an estimated $92K sold.

Bank of Montreal first reported a position in RCUS in Q2 2018 and held it in 14 quarters. The position peaked at $223K in Q4 2020. 190 funds tracked by Wall St. Rank hold RCUS as of Q3 2025.

  • Bank of Montreal reported no remaining Arcus Biosciences position as of Q3 2025 after selling out during the quarter.
  • Bank of Montreal sold 11,304 Arcus Biosciences shares in Q3 2025, an estimated $92K.
  • Bank of Montreal first reported a position in Arcus Biosciences in Q2 2018 and held it in 14 quarters.
  • Bank of Montreal's Arcus Biosciences position peaked at $223K in Q4 2020.
  • 190 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2025.

Based on Bank of Montreal's 13F filing for Q3 2025, filed 13 Nov 2025.